8-K filing — Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Filed: 2026-10-15 AccNo: 0001193125-26-422437 Size: 26 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Market-Moving News for September 14th
GLW: -8% | Corning shares are trading lower after the company announced a $2 billion offering. ELMT: 49% | Elmet Group Lands $450M US Government Investment To Expand Tungsten Manufacturing, To Invest More Than $165M
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Corbus Pharmaceuticals Announces First Patient Dosed In Registrational TEMPO-1 Study Of CRB-701 In Oropharyngeal Cancer
Shares of machinery-related companies are trading lower as rising oil prices and stronger-than-expected inflation data have reinforced expectations that U.S. interest rates will remain elevated. Elevated borrowing costs could pressure capital spending and reduce demand for heavy equipment and other large industrial purchases.
Needham Maintains Buy on The Elmet Group, Raises Price Target to $28
Needham analyst James Ricchiuti maintains The Elmet Group (NASDAQ:ELMT) with a Buy and raises the price target from $25 to $28.
The Elmet Group shares are trading higher after Canaccord Genuity raised its price target on the stock from $21 to $26.
Canaccord Genuity Maintains Buy on The Elmet Group, Raises Price Target to $26
Canaccord Genuity analyst Austin Moeller maintains The Elmet Group (NASDAQ:ELMT) with a Buy and raises the price target from $21 to $26.